MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study

Status unconfirmed · Phase 3 · Has a placebo group

Conditions studied: Ischemic Stroke

In brief

A Phase 3 study to examine the safety and effectiveness of the allogeneic, adult stem cell investigational product, MultiStem, in adults who have suffered an acute ischemic stroke in the previous 18-36 hours.

Key facts

Study ID

NCT03545607

Run by

Healios K.K.

People needed

300

Starts

2018-07-28

Expected to finish

2023-06-01

Last updated by the study team

2022-02-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Athersys Investigational Site 128 — Phoenix, Arizona, United States (enrolling)
• Athersys Investigational Site 122 — Palo Alto, California, United States (enrolling)
• Athersys Investigational Site 127 — Sacramento, California, United States (enrolling)
• Athersys Investigational Site 129 — Clearwater, Florida, United States (enrolling)
• Athersys Investigational Site 108 — Miami, Florida, United States (enrolling)
• Athersys Investigational Site 103 — Augusta, Georgia, United States (enrolling)
• Athersys Investigational Site 121 — Chicago, Illinois, United States (enrolling)
• Athersys Investigational Site 119 — Kansas City, Kansas, United States (enrolling)
• Athersys Investigational Site 124 — Wichita, Kansas, United States (enrolling)
• Athersys Investigational Site 113 — Boston, Massachusetts, United States (enrolling)
• Athersys Investigational Site 125 — Minneapolis, Minnesota, United States (enrolling)
• Athersys Investigational Site 111 — Jackson, Mississippi, United States (enrolling)
• Athersys Investigational Site 109 — Akron, Ohio, United States (enrolling)
• Athersys Investigational Site 104 — Cleveland, Ohio, United States (enrolling)
• Athersys Investigational Site 130 — Toledo, Ohio, United States (enrolling)
• Athersys Investigational Site 102 — Portland, Oregon, United States (enrolling)
• Athersys Investigational Site 107 — Hershey, Pennsylvania, United States (enrolling)
• Athersys Investigational Site 106 — Pittsburgh, Pennsylvania, United States (enrolling)
• Athersys Investigational Site 118 — Columbia, South Carolina, United States (enrolling)
• Athersys Investigational Site 115 — Chattanooga, Tennessee, United States (enrolling)
• Athersys Investigational Site 101 — Houston, Texas, United States (enrolling)
• Athersys Investigational Site 105 — Houston, Texas, United States (enrolling)
• Athersys Investigational Site 110 — Salt Lake City, Utah, United States (enrolling)
• Athersys Investigational Site 603 — Taichung, Taiwan (enrolling)
• Athersys Investigational Site 601 — Taipei, Taiwan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.